Compare RLMD & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLMD | PRE |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 319.7M | 369.7M |
| IPO Year | 2012 | N/A |
| Metric | RLMD | PRE |
|---|---|---|
| Price | $4.08 | $15.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $9.00 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 620.1K | 281.8K |
| Earning Date | 03-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,070.00 | N/A |
| Revenue This Year | N/A | $110.85 |
| Revenue Next Year | N/A | $64.36 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 154.83 | N/A |
| 52 Week Low | $0.24 | $3.09 |
| 52 Week High | $5.12 | $22.86 |
| Indicator | RLMD | PRE |
|---|---|---|
| Relative Strength Index (RSI) | 52.15 | 36.58 |
| Support Level | $3.81 | $12.71 |
| Resistance Level | $4.56 | $16.81 |
| Average True Range (ATR) | 0.35 | 2.03 |
| MACD | 0.04 | -0.58 |
| Stochastic Oscillator | 68.39 | 10.34 |
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
Prenetics Global Ltd is a health sciences company dedicated to advancing consumer health. The consumer initiative is led by IM8, one of the world's fastest-growing supplement brands; Europa, one of the sports distribution companies in the USA; and CircleDNA, a direct-to-consumer DNA testing company. As the first consumer healthcare company to establish a Bitcoin treasury with its initial approximately $20 million Bitcoin purchase and board-approved comprehensive Bitcoin plan of action, Prenetics is pioneering the intersection of healthcare innovation and digital asset adoption.